Showing 1,601 - 1,620 results of 2,274 for search '"type 2 diabetes"', query time: 0.13s Refine Results
  1. 1601

    Attitudes Regarding Participation in a Diabetes Screening Test among an Assyrian Immigrant Population in Sweden by Susanne Andersson, Veronika Karlsson, Louise Bennet, Klas Fellbrant, Margareta Hellgren

    Published 2016-01-01
    “…Immigrants from the Middle East have higher prevalence and incidence of type 2 diabetes (T2D) compared with native Swedes. The aim of the study was to describe and understand health beliefs in relation to T2D as well as attitudes regarding participation in a screening process in a local group of Assyrian immigrants living in Sweden. …”
    Get full text
    Article
  2. 1602

    Effect of Social Factors and the Natural Environment on the Etiology and Pathogenesis of Diabetes Mellitus by Guangtong Dong, Lianlian Qu, Xuefeng Gong, Bing Pang, Weitian Yan, Junping Wei

    Published 2019-01-01
    “…Type 2 diabetes mellitus (T2DM) is currently a public health problem worldwide and a threat to human health and social development. …”
    Get full text
    Article
  3. 1603

    Evaluating Traditional Chinese Medicine and Herbal Products for the Treatment of Gestational Diabetes Mellitus by Yang Xin Zi Xu, Shengyan Xi, Xiaoyan Qian

    Published 2019-01-01
    “…We further reviewed them and their relatives in relation to type 2 diabetes mellitus and found more evidence of metabolic benefits. …”
    Get full text
    Article
  4. 1604

    On the Environmental Factors Affecting the Structural and Cytotoxic Properties of IAPP Peptides by Marianna Flora Tomasello, Alessandro Sinopoli, Giuseppe Pappalardo

    Published 2015-01-01
    “…Pancreatic islets in type 2 diabetes mellitus (T2DM) patients are characterized by reduced β-cells mass and diffuse extracellular amyloidosis. …”
    Get full text
    Article
  5. 1605

    Exploring mechanisms of insulin action and strategies to treat diabetes by Takayoshi Sasako

    Published 2024-07-01
    “…Moreover, we reported the effects of intensive multifactorial intervention on diabetic vascular complications and mortality in patients with type 2 diabetes in a large-scale clinical trial, the J-DOIT3, and the results of subsequent sub-analyses of renal events and fracture events. …”
    Get full text
    Article
  6. 1606

    Management of a Difficult-to-Treat Diabetic Foot Wound Complicated by Osteomyelitis: A Case Study by Maram Alkhatieb, Hatan Mortada, Hattan Aljaaly

    Published 2020-01-01
    “…We report a case of a 51-year-old male patient, with a known history of type 2 diabetes mellitus who presented to our hospital with a history of two ulcers, one that he was mainly complaining of, which was actively infected and located at the posterior part of the distal left leg, and the second, dry ulcer caused by unrecognized trauma, located on the heel of the same limb. …”
    Get full text
    Article
  7. 1607

    Semaglutide Protects against 6-OHDA Toxicity by Enhancing Autophagy and Inhibiting Oxidative Stress by Dong-xing Liu, Chen-sheng Zhao, Xiao-na Wei, Yi-peng Ma, Jian-kun Wu

    Published 2022-01-01
    “…Studies have demonstrated that improving insulin resistance in type 2 diabetes mellitus (T2DM) can benefit patients with PD. …”
    Get full text
    Article
  8. 1608

    Modulation of Adipocytokines Production and Serum NEFA Level by Metformin, Glimepiride, and Sitagliptin in HFD/STZ Diabetic Rats by Mohamed I. Saad, Maher A. Kamel, Mervat Y. Hanafi

    Published 2015-01-01
    “…Type 2 diabetes mellitus (T2DM) is a group of metabolic disorders characterized by hyperglycemia owing to insulin resistance and/or insulin deficiency. …”
    Get full text
    Article
  9. 1609

    Cholecystoduodenal Stenting: An Option in Complicated Acute Calculous Cholecystitis in the Elderly Comorbid Patient by Brady Bonner, Nicholas I. Brown, Varghese Pynadath Joseph, Manju Dashini Chandrasegaram

    Published 2018-01-01
    “…She was unable to have a cholecystectomy due to multiple comorbidities including morbid obesity, type 2 diabetes, Guillain–Barrè syndrome, chronic sacral pressure ulcer, and severe cardiac disease. …”
    Get full text
    Article
  10. 1610

    Nutritional and Phytochemical Composition and Associated Health Benefits of Oat (Avena sativa) Grains and Oat-Based Fermented Food Products by Getaneh Firew Alemayehu, Sirawdink Fikreyesus Forsido, Yetenayet B. Tola, Endale Amare

    Published 2023-01-01
    “…Oats are a good source of soluble dietary fiber, particularly β-glucan, which has outstanding functional properties and is extremely important in human nutrition. β-Glucan has been shown to lower blood cholesterol and glucose absorption in the intestine, thereby preventing diseases such as cardiovascular injury, dyslipidemia, hypertension, inflammatory state, and type 2 diabetes. Oats also contain high concentration of antioxidant compounds. …”
    Get full text
    Article
  11. 1611

    PPARs, Cardiovascular Metabolism, and Function: Near- or Far-from-Equilibrium Pathways by Yves Lecarpentier, Victor Claes, Jean-Louis Hébert

    Published 2010-01-01
    “…Dysfunction of clock genes and PPARγ may lead to hyperphagia, obesity, metabolic syndrome, myocardial infarction and sudden cardiac death, In pathological conditions, regulatory processes of the cardiovascular system may bifurcate towards new states, such as those encountered in hypertension, type 2 diabetes, and heart failure. Numerous of these oscillatory mechanisms, organized in time and space, behave far from equilibrium and are “dissipative structures”.…”
    Get full text
    Article
  12. 1612

    Crescentic Glomerulonephritis and Membranous Nephropathy: A Rare Overlap by Mohamedanwar Ghandour, Heba Osman, Samer Alkassis, Alix Charles, Kristina Zalewski, Jarrett Weinberger, Yahya Malik-Osman, Zeenat Y. Bhat

    Published 2022-01-01
    “…Our patient is a 53-year-old Hispanic male with a medical history of tobacco use, type 2 diabetes mellitus, and hypertension who presented with hematuria and was found to have nephrotic range proteinuria and renal impairment. …”
    Get full text
    Article
  13. 1613

    Appendicitis After Initiation of Tirzepatide by Chan G, Ansar M, Klein M

    Published 2025-01-01
    “…Garrett Chan1, Mariam Ansar1, Marlena Klein1,21Department of Internal Medicine, Cooper University Hospital, Camden, New Jersey, USA; 2Cooper Medical School of Rowan University, Camden, New Jersey, USACorrespondence: Garrett Chan, Email chan-garrett@cooperhealth.eduAbstract: Tirzepatide is a GLP1/GIP receptor agonist that is used to treat type 2 diabetes and promote weight loss. Common side effects of Tirzepatide include nausea, vomiting, and diarrhea. …”
    Get full text
    Article
  14. 1614

    Role of Mitochondria-Associated Endoplasmic Reticulum Membrane in Inflammation-Mediated Metabolic Diseases by Themis Thoudam, Jae-Han Jeon, Chae-Myeong Ha, In-Kyu Lee

    Published 2016-01-01
    “…Inflammation is considered to be one of the most critical factors involved in the development of complex metabolic diseases such as type 2 diabetes, cancer, and cardiovascular disease. A few decades ago, the discovery of mitochondria-associated endoplasmic reticulum (ER) membrane (MAM) was followed by the identification of its roles in regulating cellular homeostatic processes, ranging from cellular bioenergetics to apoptosis. …”
    Get full text
    Article
  15. 1615

    Diabetic Muscle Infarction: A Rare Complication of Long-Standing and Poorly Controlled Diabetes Mellitus by Shridhar N. Iyer, Almond J. Drake, R. Lee West, Robert J. Tanenberg

    Published 2011-01-01
    “…We describe a case of a 45-year-old male with an approximately 8-year history of poorly controlled type 2 diabetes mellitus with multiple microvascular complications who presented with the sudden onset of left thigh pain and swelling. …”
    Get full text
    Article
  16. 1616

    Tigecycline-induced acute pancreatitis with electrocardiogram changes in renal insufficiency elderly by Hong Chin Wee, Ru Shing Ng, Loke Meng Ong

    Published 2024-12-01
    “…Case description: We present a case of tigecycline-induced acute pancreatitis in a 78-year-old man with complex medical conditions, including type 2 diabetes mellitus, chronic renal insufficiency, and triple vessel disease. …”
    Get full text
    Article
  17. 1617

    The Effect of Sleep Disruption on Cardiometabolic Health by SeokHyun Hong, Da-Been Lee, Dae-Wui Yoon, Seung-Lim Yoo, Jinkwan Kim

    Published 2025-01-01
    “…Epidemiological studies have consistently demonstrated that insufficient sleep duration (<7 h) and poor sleep quality are associated with increased risks of obesity, type 2 diabetes, and cardiovascular disease. The underlying mechanisms are multifaceted, involving the disruption of circadian clock genes, alterations in glucose and lipid metabolism, the activation of inflammatory pathways, and the modulation of the gut microbiome. …”
    Get full text
    Article
  18. 1618

    Clinically meaningful classes of financial toxicity for patients with diabetes by Minal R. Patel, Jonathan P. Troost, Michele Heisler, Noelle E. Carlozzi

    Published 2025-01-01
    “…Methods Data included a sample of 600 adults with Type 1 or Type 2 diabetes and high A1c. Latent Class Analysis was used to identify subgroups of patients based on COST-FACIT score patterns. …”
    Get full text
    Article
  19. 1619

    Compatibility of Whole Wheat-Based Composite Flour in the Development of Functional Foods by Amani Weerarathna, Matara Arahchige Jagath Wansapala

    Published 2024-01-01
    “…Composite flours have the potential to reduce the risk of non-communicable diseases, particularly type 2 diabetes, cardiovascular disease and cancer. It can be concluded that the use of composite flours in the food industry is a trending approach due to their numerous benefits.…”
    Get full text
    Article
  20. 1620

    Effect of Pentoxifylline on Microalbuminuria in Diabetic Patients: A Randomized Controlled Trial by Shahrzad Shahidi, Marziyeh Hoseinbalam, Bijan Iraj, Mojtaba Akbari

    Published 2015-01-01
    “…Pentoxifylline has not a significant additive antimicroalbuminuric effect compared with placebo in patients with type 2 diabetes with early stage of kidney disease; however, further clinical investigations are necessary to be done.…”
    Get full text
    Article